Radiation Oncology/Therapy: Page 331

Michigan healthcare systems form proton beam partnership
By AuntMinnie.com staff writers
A consortium of Michigan healthcare systems has created a joint venture to bring proton beam therapy cancer treatment to area patients.
June 2, 2008
FDA clears Nucletron's treatment planning product
By AuntMinnie.com staff writers
Radiation oncology firm Nucletron of Veenendaal, Netherlands, has received clearance from the U.S. Food and Drug Administration (FDA) for its volume-based treatment planning software.
June 2, 2008
ASCO news: PET studies advocated before head and neck, lung cancer surgeries
By Edward Susman
CHICAGO - Conducting an FDG-PET scan on patients with head and neck or lung cancer can help reduce unnecessary or futile surgical interventions, according to research presented this week at the 2008 American Society of Clinical Oncology (ASCO) meeting.
June 2, 2008
DW-MRI shows value in RTP for head and neck cancer
By Barbara Boughton
A pilot study presented at the 2008 American Association for Cancer Research (AACR) meeting is the first to demonstrate the value of diffusion-weighted MRI for nodal staging in head and neck squamous cell carcinoma, according to investigators from Belgium.
June 2, 2008
ASCO news: Selenium use does not interfere with radiotherapy
By Edward Susman
CHICAGO - German researchers reported that use of the nutritional supplement selenium in women who are diagnosed with gynecological cancers does not appear to compromise the effectiveness of radiation therapy. The findings could be good news for patients taking selenium for its antioxidant properties.
June 1, 2008
ASCO news: Funding shortfall closes NCI imaging programs
By Edward Susman
CHICAGO - The director of the National Cancer Institute (NCI) said that flat federal funding for cancer research during the Bush Administration since 2004 will force the closure of at least two projects aimed at developing better cancer imaging technology.
May 31, 2008
Radiation therapy for prostate cancer linked to secondary cancers
By Cynthia E. Keen
Patients undergoing external-beam radiation therapy (EBRT) for localized prostate cancer may be at an increased risk for secondary malignancies 10 or more years after initial treatment. French-Canadian men who received EBRT between 1983 and 2004 were found to have a higher prevalence of bladder, rectal, and lung cancers compared to those who had a radical prostatectomy.
May 27, 2008
Varian, Still River team up
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems and proton radiotherapy vendor Still River Systems have signed an agreement to develop an interface between Varian's Aria oncology information system and Still River's Monarch250 proton beam radiotherapy system.
May 26, 2008
FDA clears Xoft's new applicators
By AuntMinnie.com staff writers
Brachytherapy device developer Xoft of Sunnyvale, CA, has received clearance from the U.S. Food and Drug Administration for applicators to be used with its Axxent electronic brachytherapy system for the treatment of endometrial cancer.
May 20, 2008
Varian receives Danish contract
By AuntMinnie.com staff writers
Varian Medical Systems of Palo Alto, CA, has received an order from Aarhus University Hospital in Aarhus, Denmark, for three Clinac linear accelerators and nine RapidArc volumetric-arc therapy systems.
May 20, 2008
Varian deploys RapidArc in Sweden
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems is expanding the market reach of its RapidArc image-guided intensity-modulated radiotherapy (IMRT) system into Sweden.
May 19, 2008
Varian's RapidArc radiotherapy used in Europe
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems' image-guided intensity-modulated radiotherapy (IMRT) system, RapidArc, has been used by two hospitals in Denmark and the Netherlands -- its first use in Europe, according to the Palo Alto, CA-based firm.
May 14, 2008
Previous Page
Page 331 of 469
Next Page